Skip to main content

Advertisement

Log in

Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objective

To assess whether changes in MRI-based measures of thigh muscle quality associated with statin use in participants with and without/at-risk of knee osteoarthritis.

Methods

This retrospective cohort study used data from the Osteoarthritis Initiative study. Statin users and non-users were matched for relevant covariates using 1:1 propensity-score matching. Participants were further stratified according to baseline radiographic knee osteoarthritis status. We used a validated deep-learning method for thigh muscle MRI segmentation and calculation of muscle quality biomarkers at baseline, 2nd, and 4th visits. Mean difference and 95% confidence intervals (CI) in longitudinal 4-year measurements of muscle quality biomarkers, including cross-sectional area, intramuscular adipose tissue, contractile percent, and knee extensors and flexors maximum and specific contractile force (force/muscle area) were the outcomes of interest.

Results

After matching, 3772 thighs of 1910 participants were included (1886 thighs of statin-users: 1886 of non-users; age: 62 ± 9 years (average ± standard deviation), range: 45–79; female/male: 1). During 4 years, statin use was associated with a slight decrease in muscle quality, indicated by decreased knee extension maximum (mean-difference, 95% CI: − 1.85 N/year, − 3.23 to − 0.47) and specific contractile force (− 0.04 N/cm2/year, − 0.07 to − 0.01), decreased thigh muscle contractile percent (− 0.03%/year, − 0.06 to − 0.01), and increased thigh intramuscular adipose tissue (3.06 mm2/year, 0.53 to 5.59). Stratified analyses showed decreased muscle quality only in participants without/at-risk of knee osteoarthritis but not those with established knee osteoarthritis.

Conclusions

Statin use is associated with a slight decrease in MRI-based measures of thigh muscle quality over 4 years. However, considering statins’ substantial cardiovascular benefits, these slight muscle changes may be relatively less important in overall patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The de-identified clinical and demographic information of subjects is publicly available at the osteoarthritis initiative project data repository at https://oai.nih.gov.

References

  1. Fuentes AV, Pineda MD, Venkata KCN. Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy (Basel). 2018;6(2):43.

    PubMed  Google Scholar 

  2. Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532–61.

    CAS  PubMed  Google Scholar 

  3. Haj-Mirzaian A, Mohajer B, Guermazi A, Conaghan PG, Lima JAC, Blaha MJ, et al. Statin use and knee osteoarthritis outcome measures according to the presence of Heberden nodes: results from the Osteoarthritis Initiative. Radiology. 2019;293(2):190557.

    Google Scholar 

  4. Mohajer B, Guermazi A, Conaghan PG, Berenbaum F, Roemer FW, Haj-Mirzaian A, et al. Statin use and MRI subchondral bone marrow lesion worsening in generalized osteoarthritis: longitudinal analysis from Osteoarthritis Initiative data. Eur Radiol. 2022;32(6):3944–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Valdes AM, Zhang W, Muir K, Maciewicz RA, Doherty S, Doherty M. Use of statins is associated with a lower prevalence of generalised osteoarthritis. Ann Rheum Dis. 2014;73(5):943–5.

    CAS  PubMed  Google Scholar 

  6. Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015;36(17):1012–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6(3):208–15.

    PubMed  Google Scholar 

  8. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol. 2006;97(8a):52c–60c.

    CAS  PubMed  Google Scholar 

  9. Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, et al. Effect of statins on skeletal muscle function. Circulation. 2013;127(1):96–103.

    CAS  PubMed  Google Scholar 

  10. Herrett E, Williamson E, Brack K, Beaumont D, Perkins A, Thayne A, et al. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials. BMJ. 2021;372:n135.

    PubMed  PubMed Central  Google Scholar 

  11. Raynauld J-P, Pelletier J-P, Roubille C, Dorais M, Abram F, Li W, et al. Magnetic resonance imaging–assessed vastus medialis muscle fat content and risk for knee osteoarthritis progression: relevance from a clinical trial. Arthritis Care Res. 2015;67(10):1406–15.

    Google Scholar 

  12. Kumar D, Link TM, Jafarzadeh SR, LaValley MP, Majumdar S, Souza RB. Association of quadriceps adiposity with an increase in knee cartilage, meniscus, or bone marrow lesions over three years. Arthritis Care Res. 2021;73(8):1134–9.

    CAS  Google Scholar 

  13. Morse CI, Thom JM, Reeves ND, Birch KM, Narici MV. In vivo physiological cross-sectional area and specific force are reduced in the gastrocnemius of elderly men. J Appl Physiol (1985). 2005;99(3):1050–5.

    PubMed  Google Scholar 

  14. Culvenor AG, Felson DT, Niu J, Wirth W, Sattler M, Dannhauer T, et al. Thigh muscle specific-strength and the risk of incident knee osteoarthritis: the influence of sex and greater body mass index. Arthritis Care Res. 2017;69(8):1266–70.

    Google Scholar 

  15. Culvenor AG, Hamler FC, Kemnitz J, Wirth W, Eckstein F. Brief report: loss of muscle strength prior to knee replacement: a question of anatomic cross-sectional area or specific strength? Arthritis Rheumatol. 2018;70(2):222–9.

    PubMed  Google Scholar 

  16. Morville T, Dohlmann TL, Kuhlman AB, Sahl RE, Kriegbaum M, Larsen S, et al. Aerobic exercise performance and muscle strength in statin users-the LIFESTAT study. Med Sci Sports Exerc. 2019;51(7):1429–37.

    CAS  PubMed  Google Scholar 

  17. Lawrence JS. The epidemiology of chronic rheumatism. Ann Rheum Dis. 1964;23(1):81.

    PubMed Central  Google Scholar 

  18. Rantanen T, Era P, Heikkinen E. Maximal isometric strength and mobility among 75-year-old men and women. Age Ageing. 1994;23(2):132–7.

    CAS  PubMed  Google Scholar 

  19. Peterfy CG, Schneider E, Nevitt M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis and cartilage. 2008;16(12):1433–1441.

  20. Mohajer B, Dolatshahi M, Moradi K, Najafzadeh N, Eng J, Zikria B, et al. Role of thigh muscle changes in knee osteoarthritis outcomes: Osteoarthritis Initiative data. Radiology. 2022;305(1):169–78.

    PubMed  Google Scholar 

  21. Ahmad E, McPhee J, Degens H, Yap MH. Automatic segmentation of MRI human thigh muscles: combination of reliable and fast framework methods for quadriceps, femur and marrow segmentation. In Proceedings of the 2018 8th International Conference on Biomedical Engineering and Technology (ICBET '18). Association for Computing Machinery, New York, NY; 2018. p. 31–38

  22. Ogawa M, Yoshiko A, Tanaka N, Koike T, Oshida Y, Akima H. Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images. PLoS One. 2020;15(4):e0231156–e0231156.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Moser M, AdlAmini D, Echeverri C, Oezel L, Haffer H, Muellner M, et al. Changes in psoas and posterior paraspinal muscle morphology after standalone lateral lumbar interbody fusion: a quantitative MRI-based analysis. Eur Spine J. 2023;32(5):1704–13.

    PubMed  Google Scholar 

  24. Fortin M, Omidyeganeh M, Battié MC, Ahmad O, Rivaz H. Evaluation of an automated thresholding algorithm for the quantification of paraspinal muscle composition from MRI images. Biomed Eng Online. 2017;16(1):61–61.

    PubMed  PubMed Central  Google Scholar 

  25. Ogier AC, Hostin MA, Bellemare ME, Bendahan D. Overview of MR image segmentation strategies in neuromuscular disorders. Frontiers in Neurology. 2021; 12:625308.

  26. Lee D, Hong K-T, Lee W, Khil EK, Lee GY, Choi J-A, et al. Threshold-based quantification of fatty degeneration in the supraspinatus muscle on MRI as an alternative method to Goutallier classification and single-voxel MR spectroscopy. BMC Musculoskelet Disord. 2020;21(1):362.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Ogawa M, Lester R, Akima H, Gorgey AS. Quantification of intermuscular and intramuscular adipose tissue using magnetic resonance imaging after neurodegenerative disorders. Neural Regen Res. 2017;12(12):2100–5.

    PubMed  PubMed Central  Google Scholar 

  28. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.

    CAS  PubMed  Google Scholar 

  29. Baldwin CE, Paratz JD, Bersten AD. Muscle strength assessment in critically ill patients with handheld dynamometry: an investigation of reliability, minimal detectable change, and time to peak force generation. J Crit Care. 2013;28(1):77–86.

    PubMed  Google Scholar 

  30. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137(7):581–5.

    PubMed  Google Scholar 

  31. Biltz NK, Collins KH, Shen KC, Schwartz K, Harris CA, Meyer GA. Infiltration of intramuscular adipose tissue impairs skeletal muscle contraction. J Physiol. 2020;598(13):2669–83.

    CAS  PubMed  Google Scholar 

  32. Loenneke JP, Loprinzi PD. Statin use may reduce lower extremity peak force via reduced engagement in muscle-strengthening activities. Clin Physiol Funct Imaging. 2018;38(1):151–4.

    CAS  PubMed  Google Scholar 

  33. Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625–33.

    CAS  PubMed  Google Scholar 

  34. Robles PG, Sussman MS, Naraghi A, Brooks D, Goldstein RS, White LM, et al. Intramuscular fat infiltration contributes to impaired muscle function in COPD. Med Sci Sports Exerc. 2015;47(7):1334–41.

    PubMed  Google Scholar 

  35. Lee KH, Gao Y, Lau V. Statin-associated anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) myopathy: imaging findings on thigh-muscle magnetic resonance imaging (MRI) in six patients. Muscle Nerve. 2021;64(4):500–4.

    CAS  PubMed  Google Scholar 

  36. Wagner M, Mühldorfer-Fodor M, Prommersberger KJ, Schmitt R. Statin-induced focal myositis of the upper extremity. A report of two cases. Eur J Radiol. 2011;77(2):258–60.

    CAS  PubMed  Google Scholar 

  37. Amit P, Kuiper JH, James S, Snow M. Does statin-treated hyperlipidemia affect rotator cuff healing or muscle fatty infiltration after rotator cuff repair? J Shoulder Elbow Surg. 2021;30(11):2465–74.

    PubMed  Google Scholar 

  38. Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res. 1994;304:78–83.

    Google Scholar 

  39. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–8.

    CAS  PubMed  Google Scholar 

  40. Veronese N, Koyanagi A, Stubbs B, Cooper C, Guglielmi G, Rizzoli R, et al. Statin use and knee osteoarthritis outcomes: a longitudinal cohort study. Arthritis Care Res (Hoboken). 2019;71(8):1052–8.

    CAS  PubMed  Google Scholar 

  41. Haj-Mirzaian A, Mohajer B, Guermazi A, Conaghan PG, Lima JAC, Blaha MJ, et al. Statin use and knee osteoarthritis outcome measures according to the presence of Heberden nodes: results from the Osteoarthritis Initiative. Radiology. 2019;293(2):396–404.

    PubMed  Google Scholar 

  42. Hafferty JD, Campbell AI, Navrady LB, Adams MJ, MacIntyre D, Lawrie SM, et al. Self-reported medication use validated through record linkage to national prescribing data. J Clin Epidemiol. 2018;94:132–42.

    PubMed  PubMed Central  Google Scholar 

  43. Mueller AM, Liakoni E, Schneider C, Burkard T, Jick SS, Krähenbühl S, et al. The risk of muscular events among new users of hydrophilic and lipophilic statins: an observational cohort study. J Gen Intern Med. 2021;36(9):2639–47.

    PubMed  PubMed Central  Google Scholar 

  44. Chan DC, Gan SK, Wong AT, Barrett PH, Watts GF. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss. Diabetes Obes Metab. 2014;16(10):994–1000.

    CAS  PubMed  Google Scholar 

  45. Hollingsworth KG, Garrood P, Eagle M, Bushby K, Straub V. Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve. 2013;48(4):586–8.

    PubMed  Google Scholar 

  46. Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29(6):1310–20.

    PubMed  PubMed Central  Google Scholar 

  47. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr. 2007;85(2):377–84.

    CAS  PubMed  Google Scholar 

  48. Hogrel J-Y, Barnouin Y, Azzabou N, Butler-Browne G, Voit T, Moraux A, et al. NMR imaging estimates of muscle volume and intramuscular fat infiltration in the thigh: variations with muscle, gender, and age. Age. 2015;37(3):60.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The Osteoarthritis Initiative, a collaborative project between public and private sectors, includes five contracts N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, and N01-AR-2-2262. This project is conducted by the Osteoarthritis Initiative project investigators and is financially supported by the National Institutes of Health (NIH). Merck Research Laboratories, Novartis Pharmaceuticals Corporation, GlaxoSmithKline, and Pfizer, Inc. were the private funding partners.

In preparing this manuscript, osteoarthritis initiative project publicly available datasets were used. The results of this work do not necessarily reflect the opinions of the osteoarthritis initiative project investigators, the NIH, or the private funding partners.

Funding

This research was supported by the NIH National Institute of Aging (NIA) under Award Number P01AG066603 and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under Award Number R01AR079620-01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bahram Mohajer.

Ethics declarations

Ethics approval

The medical ethics review boards of the University of California, San Francisco (Approval Number: 10–00532) and the four clinical centers of Osteoarthritis Initiative project recognized the project as Health Insurance Portability and Accountability Act (HIPAA)-compliant. This project was in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments, and all individuals gave their informed consent prior to their inclusion in the study. The authors of this manuscript certify that they comply with the ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia, and Muscle.

Patient consent

Subjects have given informed consent before participating in the Osteoarthritis Initiative (OAI) project.

Conflict of interest

None of the authors has any conflicting personal or financial relationships with the organization that sponsored the research (NIH) that could have influenced the results of this study. FWR is chief marketing officer and shareholder of Boston Imaging Core Lab (BICL), LLC, and consultant to Calibr — California Institute of Biomedical Research and Grünenthal GmbH. AG is a shareholder of BICL and consultant to Pfizer, TissueGene, MerckSerono, Novartis, Regeneron, and AstraZeneca. SD reported that he received funding from Toshiba Medical Systems (for consultation) and grants from GERRAF and Carestream Health (for a clinical trial study). PGC is supported in part through the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Other authors declare that they did not have any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 429 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohajer, B., Moradi, K., Guermazi, A. et al. Statin use and longitudinal changes in quantitative MRI-based biomarkers of thigh muscle quality: data from Osteoarthritis Initiative. Skeletal Radiol 53, 683–695 (2024). https://doi.org/10.1007/s00256-023-04473-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-023-04473-7

Keywords

Navigation